THE PEER-REVIEWED FORUM FOR EVIDENCE IN BENEFIT DESIGN ™ JUNE/JULY 2009
VOLUME 2, NUMBER 4
EDITORIAL
Prioritizing Healthcare Resources Robert E. Henry
The View from Washington: Healthcare Reform John Gorman
REGULATORY
Applying Evidence for Medical Technologies Interview with Sean R. Tunis, MD, MSc ™
Stakeholder Perspective by F. Randy Vogenberg, RPh, PhD BUSINESS
The Working Patient with Cancer: Implications for Payers and Employers Grant D. Lawless, BSPharm, MD, FACP
Stakeholder Perspective by Gary M. Owens, MD
Predictors of First-Fill Adherence to New Asthma Prescriptions Zackary Berger, MD, PhD; William Kimbrough, MD; Colleen Gillespie, PhD; Joseph A. Boscarino, PhD, MPH; G. Craig Wood, MS; Zhengmin Qian, MD, PhD; J. B. Jones, PhD, MBA; Nirav R. Shah, MD, MPH
Stakeholder Perspective by Ronald A. Lyon, MS CLINICAL
Use Pattern and Off-Label Use of Atypical Antipsychotics in Bipolar Disorder Jeffery A. Demland, MS; Yonghua Jing, BPharm, PhD; Christina M. L. Kelton, PhD; Jeff J. Guo, BPharm, MS, PhD; Hong Li, MPH, PhD; Patricia R. Wigle, PharmD
Stakeholder Perspective by Renee Rizzo Fleming, RPh, MBA DEPARTMENTS ◆ Generic Drug Trends Biosimilars Policy Forum: Perspectives on Safety and Efficacy of Future Products ◆ Industry Trends Payer Perspectives on Healthcare Reform CONTINUING EDUCATION
Workplace Wellness and Disease Prevention: Focus on COPD David Tinkelman, MD; William B. Bunn, III, MD, JD, MPH; F. Randy Vogenberg, RPh, PhD
©2009 Engage Healthcare Communications, LLC www.AHDBonline.com